arrow
M

Mateusz M. Pluciński

Centers for Disease Control and Prevention
H指数:34
被引数:3,550

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data

延长青蒿琥酯-本芴醇治疗无并发症恶性疟的疗程:基于监测、咨询和已发表数据评审的美国疾病控制与预防中心更新指南

2026-08-190
OAAI
Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria among children 6-59 months in three sentinel sites of Sierra Leone, 2021-2022

2021-2022年塞拉利昂三个哨点监测点6-59个月儿童中,青蒿琥酯-本芴醇(AL)和青蒿琥酯-阿莫地喹(ASAQ)治疗非复杂型恶性疟疾的疗效与安全性

2026-04-090
PRE
Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020-2021

2020-2021年布基纳法索地区使用青蒿琥酯-苯芴醇、双氢青蒿素-哌喹、青蒿素-哌喹三联疗法治疗无并发症恶性疟原虫疟疾的疗效研究

2025-12-010
PRE
Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022-2023

2022-2023年利比里亚治疗无并发症恶性疟原虫疟疾时,青蒿琥酯-本芴醇(AL)和青蒿琥酯-阿莫地喹(ASAQ)的疗效与安全性。

2025-10-060
OAAI
Incidence of and Risk Factors for SARS-CoV-2 Infection Among Vaccinated Healthcare Workers During Emergence of SARS-CoV-2 Gamma Variant in the Amazon Region, Brazil, 2021

巴西亚马逊地区2021年SARS-CoV-2 Gamma变种出现期间,接种疫苗的卫生保健工作者中SARS-CoV-2感染的发病率和危险因素

2025-07-010
PRE
Antibody Response in Healthcare Workers During the Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Variant Outbreak in Manaus, Brazil

在巴西马瑙斯严重急性呼吸综合征冠状病毒2型Gamma变异株爆发期间,医疗保健工作者的抗体应答

2025-07-010
PRE
Principal component analysis of the Serological response to Plasmodium Falciparum using a Multiplex bead-based assay in Nigeria
2024-12-280
OAAI
Therapeutic response to four artemisinin-based combination therapies in Angola, 2021
2024-04-032
OAAI
Targeted and whole-genome sequencing reveal a north-south divide in P. falciparum drug resistance markers and genetic structure in Mozambique
2023-06-089
OAAI
Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019
2023-04-181
OAAI
Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia
2022-05-275
OA